All posts by: Michael Zand

Gene Therapy for Rare Form of Blindness Approved in US – Voice of America

The HinduGene Therapy for Rare Form of Blindness Approved in USVoice of AmericaAmerican health officials recently approved the first gene therapy treatment for an inherited disease – the type that can pass from parent to child. The treatment improves t… Continue reading

Gene Therapy for Rare Form of Blindness Approved in US – Voice of America

The HinduGene Therapy for Rare Form of Blindness Approved in USVoice of AmericaAmerican health officials recently approved the first gene therapy treatment for an inherited disease – the type that can pass from parent to child. The treatment improves t… Continue reading

Diagnosis leads to new life mission for Fairview man – The Tennessean

The TennesseanDiagnosis leads to new life mission for Fairview manThe TennesseanA cancer diagnosis has led to a new mission in life for one Fairview man. “Leukemia is a scary word,” said Ken Weaver, who was diagnosed with cancer of the blood cells in … Continue reading

US company pushes stem cell investments – The Manila Times

US company pushes stem cell investmentsThe Manila TimesMARLBOROUGH, Massachusett: As new research has expanded the use of stem cells, the Marlborough-based New England Cord Blood Bank (NECBB) Inc. has provided access to those who wish to cryogenically … Continue reading

Just how revolutionary is stem cell injectable facial rejuvenation? Here’s what you need to know. – Mic

For Localized NSCLC, Vaccine-Based Immunotherapy Does Not Affect Survival – Journal of Clinical Pathways

For Localized NSCLC, Vaccine-Based Immunotherapy Does Not Affect SurvivalJournal of Clinical PathwaysVaccine-based immunotherapy after surgery or radiotherapy did not increase survival in patients with localized non-small-cell lung cancer (NSCLC), acco… Continue reading